Grantham, Mayo, Van Otterloo & Co (GMO)
IMPV

Grantham, Mayo, Van Otterloo & Co (GMO)’s Imperva, Inc. IMPV Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-240,000
Closed -$9.22M – 669
2016
Q4 		$9.22M Hold
240,000
– – 0.05% 192
2016
Q3 		$12.9M Buy
+240,000
New +$11.1M 0.06% 187

Other funds holding IMPV

EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s IMPV Position: Q1 2017 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Imperva, Inc. (IMPV) in Q1 2017, closing a stake of 157,708 shares — an estimated $6.06M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in IMPV in Q3 2016 and held it in 2 quarters. The position peaked at $6.06M in Q4 2016. 182 funds tracked by Wall St. Rank hold IMPV as of Q1 2017.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Imperva, Inc. position as of Q1 2017 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 157,708 Imperva, Inc. shares in Q1 2017, an estimated $6.06M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Imperva, Inc. in Q3 2016 and held it in 2 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Imperva, Inc. position peaked at $6.06M in Q4 2016.
  • 182 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2017.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2017, filed 15 May 2017.